Skip to content

Xtant Medical Holdings XTNT Financing Cash Flow

Financing Cash Flow at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$530M-94.9%
Stryker logo
StrykerSYK
-$1.51B-160%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$63.97M+9,926%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
-$369.2M-164%
Globus Medical logo
Globus MedicalGMED
$18.2M+103%
Alphatec Holdings logo
Alphatec HoldingsATEC
-$1.77M-106%

Other financials

Income statement

See full
Revenue$20.9M-36.5%
Gross profit$12.0M-40.9%
Operating income-$2.9M-375%
Net income-$3.1M-5,426%
EPS (diluted)-$0.02

Balance sheet

See full
Cash & equivalents$12.2M+124%
Total debt$15.0M-34.9%
Total equity$48.6M+10.8%
Total assets$78.0M-18.6%

Cash flow

See full
Operating cash flow-$2.1M-265%
CapEx$194.0K-83.7%
Free cash flow-$2.3M-2,753%

Valuation

See full
Market cap$59.05M-32.5%
Enterprise value$61.89M-41.5%
P/E32.3×
P/S0.5×-0.2×

Profitability

See full
Gross margin62.3%+4.2pp
Operating margin4.8%+2.8pp
Net margin1.5%+0.8pp
FCF margin6.4%+4.1pp

Returns & leverage

See full
Return on equity3.9%+2.1pp
Debt / equity0.3×-0.2×
Current ratio3.3×+1.0×

Where this comes from

Reported directly by Xtant Medical Holdings in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Xtant Medical Holdings’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xtant Medical Holdings's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xtant Medical Holdings's financing cash flow?
Xtant Medical Holdings (XTNT) reported financing cash flow of -$13.28M in Q1 2026.
How has Xtant Medical Holdings's financing cash flow changed year-over-year?
Xtant Medical Holdings's financing cash flow decreased by 1344.5% year-over-year, from -$919K to -$13.28M.
What is the long-term trend for Xtant Medical Holdings's financing cash flow?
Over 3 years (2022 to 2025), Xtant Medical Holdings's financing cash flow has grown at a 4.3% compound annual growth rate (CAGR), from $9.02M to -$10.23M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.